PMC:7546716 / 1267-1469 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T22","span":{"begin":65,"end":67},"obj":"Body_part"},{"id":"T23","span":{"begin":109,"end":114},"obj":"Body_part"},{"id":"T24","span":{"begin":123,"end":127},"obj":"Body_part"},{"id":"T25","span":{"begin":140,"end":148},"obj":"Body_part"}],"attributes":[{"id":"A22","pred":"fma_id","subj":"T22","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A23","pred":"fma_id","subj":"T23","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A24","pred":"fma_id","subj":"T24","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A25","pred":"fma_id","subj":"T25","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"se hypothetical pathways, including use of therapies that target IL-33 (eg, anti-ST2), T helper 17-like γδ T cells, immune cell homing, and cytokine balance.\n\nIntroduction\nIntensive efforts are underway"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T12","span":{"begin":81,"end":84},"obj":"http://purl.obolibrary.org/obo/CLO_0051025"},{"id":"T13","span":{"begin":107,"end":114},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T14","span":{"begin":123,"end":127},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"se hypothetical pathways, including use of therapies that target IL-33 (eg, anti-ST2), T helper 17-like γδ T cells, immune cell homing, and cytokine balance.\n\nIntroduction\nIntensive efforts are underway"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T13","span":{"begin":65,"end":67},"obj":"Chemical"}],"attributes":[{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A14","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"se hypothetical pathways, including use of therapies that target IL-33 (eg, anti-ST2), T helper 17-like γδ T cells, immune cell homing, and cytokine balance.\n\nIntroduction\nIntensive efforts are underway"}

{"project":"LitCovid-sentences","denotations":[{"id":"T10","span":{"begin":159,"end":171},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"se hypothetical pathways, including use of therapies that target IL-33 (eg, anti-ST2), T helper 17-like γδ T cells, immune cell homing, and cytokine balance.\n\nIntroduction\nIntensive efforts are underway"}

{"project":"LitCovid-PubTator","denotations":[{"id":"30","span":{"begin":65,"end":70},"obj":"Gene"},{"id":"31","span":{"begin":81,"end":84},"obj":"Gene"},{"id":"32","span":{"begin":72,"end":74},"obj":"Gene"}],"attributes":[{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"Gene:90865"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"Gene:6761"},{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"Gene:50512"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"se hypothetical pathways, including use of therapies that target IL-33 (eg, anti-ST2), T helper 17-like γδ T cells, immune cell homing, and cytokine balance.\n\nIntroduction\nIntensive efforts are underway"}